Theragenics Corporation is a medical device company serving the surgical products and cancer treatment markets. The Company operates in two business segments: surgical products segment and brachytherapy seed segment. The Company's surgical products business manufactures, markets and sells disposable devices primarily utilized in certain surgical procedures. The Company's brachytherapy seed business manufactures, markets and sells radioactive seeds primarily utilized in the treatment of early stage prostate cancer. The Company designs , manufacture, assemble, package and distributes its surgical products in three primary production facilities, each of which manufactures different products. The product lines in its surgical products business include Sutures, Elite HV Introducer Kits, Radial Artery Access Kits, Biopsy Needles, Orthopedic Needles, Pain Management Needles and Access Needles. On February 17, 2012, the Company acquired Core Oncology�s prostate brachytherapy customer base.